Label Image (Lbl530022366)
Venlafaxine Hydrochloride
Product Images NDC 53002-2366
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 53002-2366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
The text provides recommendations on the interaction of the drug cimetane with analyte aniatxine, veniatxine, and venistaxing, with PK fold change and 90% CI. It suggests using caution while using the drugs and monitoring blood pressure as their clinical significance is unknown. The text also recommends not adjusting the dose of the drugs and considering factors like renal and hepatic function.*
Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)
Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)
Not Available.*
Chemical Structure (Venlafaxine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
